Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer. - Wikidata - wikimedia - TriplyDB

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.

http://www.wikidata.org/entity/Q36052315

about

Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals Frequency of HER2/neu overexpression in adenocarcinoma of the gastrointestinal system.Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer.Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification.Association of Kruppel-like factor 4 expression with the prognosis of esophageal squamous cell carcinoma patients.Imaging strategies in the management of oesophageal cancer: what's the role of MRI?A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy.SIRT1 expression is associated with lymphangiogenesis, lymphovascular invasion and prognosis in pN0 esophageal squamous cell carcinoma.The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience.Preliminary Suggestion about Staging of Anorectal Malignant Melanoma May Be Used to Predict Prognosis.Carcinoma of the gastroesophageal junction in Chinese patients.Metastatic lymph node ratio, 6th or 7th AJCC edition: witch is the best lymph node classification for esophageal cancer? Prognosis factor analysis in 487 patients.Plasma miRNA-506 as a Prognostic Biomarker for Esophageal Squamous Cell Carcinoma Evaluation of the 7(th) edition of the UICC-AJCC tumor, node, metastasis classification for esophageal cancer in a Chinese cohort.CEP55 overexpression predicts poor prognosis in patients with locally advanced esophageal squamous cell carcinoma.Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.Mitochondrial pyruvate carrier function is negatively linked to Warburg phenotype in vitro and malignant features in esophageal squamous cell carcinomas.Systematic analysis of mRNA expression profiles in NSCLC cell lines to screen metastasis-related genes Preoperative T Staging of Potentially Resectable Esophageal Cancer: A Comparison between Free-Breathing Radial VIBE and Breath-Hold Cartesian VIBE, with Histopathological Correlation TNM Staging Matched-pair Comparison of Surgery After Neoadjuvant Chemoradiotherapy, Surgery Alone and Definitive Chemoradiotherapy for Thoracic Esophageal Squamous Cell Carcinoma.Lymph node dissection for esophageal cancer.Extent of lymph node removal during esophageal cancer surgery and survival.Targeted next-generation sequencing of commonly mutated genes in esophageal adenocarcinoma patients with long-term survival.Lymph node station ratio: Revised nodal category for resected esophageal squamous cell carcinoma patients.Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma.ALDH1A1 defines invasive cancer stem-like cells and predicts poor prognosis in patients with esophageal squamous cell carcinoma.The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.Survival outcomes of 220 consecutive patients with three-staged thoracoscopic esophagectomy.Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation.The prognostic value of metastatic lymph node number and ratio in oesophageal squamous cell carcinoma patients with or without neoadjuvant chemoradiation.Tumour staging of oesophageal cancer in the Swedish Cancer Registry: A nationwide validation study.Prognostic significance of the size and number of lymph nodes on pre and post neoadjuvant chemotherapy CT in patients with pN0 esophageal squamous cell carcinoma: a 5-year follow-up study.Safety and feasibility of near-infrared image-guided lymphatic mapping of regional lymph nodes in esophageal cancer.Does neoadjuvant treatment before oncologic esophagectomy affect the postoperative quality of life? A prospective, longitudinal outcome study.Evaluation of the nodal status in the 7th edition of the UICC-TNM classification for esophageal squamous cell carcinoma: proposed modifications for improved survival stratification : impact of lymph node metastases on overall survival after esophage A multifactorial histopathologic score for the prediction of prognosis of resected esophageal adenocarcinomas after neoadjuvant chemotherapy.Validation of the eighth clinical American Joint Committee on Cancer stage grouping for esophageal cancer.Application of serial section method to determine the radiotherapy target volume for esophageal squamous carcinoma.

P2860

Q30240273-E7C2D8E0-813B-4761-BAAB-9B7DADCFC243 Q33626875-7127D098-4C11-4E60-8DD5-64B934F1358D Q33841851-CA754FCA-A6BD-4B85-BDD5-4EEC2A10333E Q34404209-B5049202-EF88-42C7-8619-F2B8857BA894 Q34501671-D083760B-F66B-4A26-951A-BFF800F9E104 Q34583617-F67D9C12-6D21-4494-A7F0-101119EE7430 Q35218636-F344253F-986B-40A9-A051-7CBBD49316C0 Q35496579-B465CCC0-417D-4058-B371-FC78CDBD538E Q35546301-0E473690-3C1A-4DF2-B576-4F8513EFCCE3 Q35692579-8218C0F7-E0B1-4C3C-BF22-C1E1C7D854D2 Q36482531-2FA8CD74-7301-49BB-8935-E384CF8C7B7E Q36529125-4913F6FA-D64D-47A7-A852-320DF2AE0B5D Q36533205-8F3EEF26-F47D-4E80-9E0A-9D6EA8204494 Q37052433-56C051B6-2092-4A5A-8187-231A3D31AFB0 Q37121508-2E24D5E8-5F0D-4E53-9E79-8B69D8AF5AD9 Q37593928-476171EC-153E-4402-BB52-7A76E60321FD Q37697151-9BEF5FBD-6491-4D2E-82C5-694A20522548 Q37702044-67455D53-E921-45B4-AB81-F3BF92D62F37 Q37707574-FD6ECA42-DC2A-4D76-B0C6-8903307C019F Q37712152-EFA88C2A-3637-4974-8C58-0541F128EE8E Q37726430-5C7237DD-B217-4526-8502-43A5F171C848 Q38093060-F9E577B3-4E9F-4EB7-9E21-9EAB644BB914 Q38415884-B173CB67-4804-4536-B7CB-B0705A6737B6 Q38634870-4D4DA363-7CA4-4429-A5FC-21C5E41490C6 Q38681123-49B19440-8A4C-4FD0-88F7-30EEDB33F173 Q38686553-95A1FE73-B4EB-457E-B8F0-326AD6B68F87 Q39066150-31C4A20C-41D3-4478-9650-40A31E9FE7D2 Q39183864-68FF972D-3FAA-4547-96CE-4F1041546C75 Q40351556-E7BFB516-1661-4835-B3E6-CEBC44A84648 Q40378167-7A4D1AAC-B392-4529-B054-52414C632D46 Q40476337-ADF07DB3-AAEA-48EA-A1F9-AB4A51AB9369 Q40900360-C6E6CD9F-672A-4BEA-8BF8-13AEA7249F79 Q41175650-3D3ADABB-F5A6-4150-8096-E7913124FEE5 Q41781597-067D169F-C481-4466-BEE6-542B08D73E56 Q42175577-BE37D01B-95C4-4353-ABCF-E724CCC97FF5 Q43746152-387B74A8-F29A-415F-BA4D-09A49E36B00E Q44922322-01C44FC7-CDDA-4271-AC40-11E3E4BE1E4E Q45716440-6490B49F-3342-48E2-807E-6A0D9C78C752 Q46731469-D2BC9D40-C8D0-475B-8A18-02B88B355CC0 Q46945838-191AAB2E-5D11-41D3-9202-C3E2C3D421F3

P2860

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.

http://www.wikidata.org/entity/Q36052315

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Comparison of the 6th and 7th ...... ication for Esophageal Cancer.

@ast

Comparison of the 6th and 7th ...... ication for Esophageal Cancer.

@en

type

label

Comparison of the 6th and 7th ...... ication for Esophageal Cancer.

@ast

Comparison of the 6th and 7th ...... ication for Esophageal Cancer.

@en

prefLabel

Comparison of the 6th and 7th ...... ication for Esophageal Cancer.

@ast

Comparison of the 6th and 7th ...... ication for Esophageal Cancer.

@en

P1433

Q36052315-B29177AB-83BE-40D3-927B-DCB562AC5D84

P1476

Q36052315-7E2C91C6-99FC-4BBD-9F11-4F557175CF88

P2093

Q36052315-072F6078-A6F7-45B0-9988-514A337D0D26

Q36052315-11CDEA86-3C06-4856-A0B4-E7B192323056

Q36052315-3F0D0329-841B-42AC-B63D-7641EB889037

Q36052315-C990046C-E361-48ED-A153-F6A7DE21BB6E

Q36052315-E09E7C41-AFD2-4174-B46F-5020BB2D79C7

Q36052315-FFA59A8F-018C-40A5-A426-F9F14FBA2B8C

P2860

Q36052315-0D47A7C4-27DF-4578-9B2C-88E64E737AF1

Q36052315-215A62DB-B8A4-4579-B8D9-A2A908455392

Q36052315-4081D77F-DCA9-4967-88DC-993830DB1B1E

Q36052315-41D26EE4-7F9A-4FDD-8F85-574B55A28CCB

Q36052315-6B2E8771-1047-4484-8BDF-BCF2176AB094

Q36052315-8C9D8B31-8810-4D5A-B3FE-1CA15B98CDAC

Q36052315-D8D0F13A-ACA1-41E4-82AF-9B90E6452AB1

Q36052315-EC083435-7CC1-41FE-A546-D5F4A6DA5918

Q36052315-F6CA4082-EDEC-44F3-864D-A660F1D3CCC9

Q36052315-FF09B5C2-CCE9-49CD-B04B-040BC4B6C03C

P2888

Q36052315-6B127E8F-FD87-477F-8E7A-2C629805A1F2

P304

Q36052315-934E972C-7C23-4D07-AC24-9AD85BCFDD33

P31

Q36052315-021261D6-CF2D-4149-AF68-DB37750736D7

P356

Q36052315-D989A234-4F54-45C6-904D-309211A819F1

P433

Q36052315-3BC71A7F-3FCE-4687-9AD2-01581105D5C1

P478

Q36052315-D3D0C9DC-7EEA-465E-B67A-08336B2886A4

P50

Q36052315-B48E7E1C-CED8-45B6-85C1-591EA8507022

P577

Q36052315-5F77A38B-ABB1-4BE0-93A8-FFAA2D9B33FF

P5875

Q36052315-AE5A0238-E83E-4015-BD66-2905A245BB8A

P6179

Q36052315-BF99BE7F-9E0E-4700-910F-F6DEACFC5086

P698

Q36052315-04C251A4-8D4E-4530-B63D-57E598C90590

P932

Q36052315-19BB3A25-3E37-487F-BB16-B79E1BD3D7B2

P356

S10434-012-2218-5

P1433

Annals of Surgical Oncology

P1476

Comparison of the 6th and 7th ...... ication for Esophageal Cancer.

@en

P2093

Bas P L Wijnhoven

http://www.w3.org/2001/XMLSchema#string

Brechtje A Grotenhuis

http://www.w3.org/2001/XMLSchema#string

Hugo W Tilanus

http://www.w3.org/2001/XMLSchema#string

Jan J B van Lanschot

http://www.w3.org/2001/XMLSchema#string

Koen Talsma

http://www.w3.org/2001/XMLSchema#string

Pieter van Hagen

http://www.w3.org/2001/XMLSchema#string

P2860

Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Classification of adenocarcinoma of the oesophagogastric junction.

Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens.

Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes.

Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: impact of staging endosonography.

Worldwide esophageal cancer collaboration.

The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.

Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma.

Patient preferences for the disclosure of prognosis after esophagectomy for cancer with curative intent.

P2888

s10434-012-2218-5

P304

2142-2148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-012-2218-5

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Ewout W. Steyerberg

P577

2012-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221682819

http://www.w3.org/2001/XMLSchema#string

P6179

1049137926

http://www.w3.org/2001/XMLSchema#string

P698

22395974

http://www.w3.org/2001/XMLSchema#string

P932

3381120

http://www.w3.org/2001/XMLSchema#string